BiomeSense
Leveraging the power of big data & AI to unlock microbiome precision medicine.
Chicago, United States · Founded 2018
- Headquarters
- Chicago, Illinois
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2C
- Website
- biomesenseinc.com
- Last Round
- Venture RoundOct 2025
- Rounds
- 5
About
BiomeSense develops AI-enabled technology platforms for continuous gut microbiome tracking and precision medicine. Their GutLab device enables at-home longitudinal sample collection, while the MetaBiome AI platform analyzes microbiome data to identify clinically relevant patterns for biomarker discovery and therapeutic development.
Summary
BiomeSense is a Biotech company based in Chicago, United States, founded in 2018. Its most recent funding was a Venture Round round in Oct 2025. Investors include Bluestein & Associates, Labcorp Venture Fund and Emil Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2025
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...